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Solute carriers (SLCs), the second largest super-family of membrane proteins in the human genome,
transport amino acids, sugars, fatty acids, inorganic ions, essential metals and drugs over membranes.
To date no study has provided a comprehensive analysis of SLC localization along the entire GI tract.
The aim of the present study was to provide a comprehensive, segment-speciﬁc description of the local-
ization of SLC genes along the rat GI tract by employing bioinformatics and molecular biology methods.
The Unigene database was screened for rat SLC entries in the intestinal tissue. Using qPCR we measured
expression of the annotated genes in the GI tract divided into the following segments: the esophagus, the
corpus and the antrum of the stomach, the proximal and distal parts of the duodenum, ileum, jejunum
and colon, and the cecum. Our Unigene-derived gene pool was expanded with data from in-house tissue
panels and a literature search. We found 44 out of 78 (56%) of gut SLC transcripts to be expressed in all GI
tract segments, whereas the majority of remaining SLCs were detected in more than ﬁve segments. SLCs
are predominantly expressed in gut regions with absorptive functions although expression was also
found in segments unrelated to absorption. The proximal jejunum had the highest number of differen-
tially expressed SLCs. In conclusion, SLCs are a crucial molecular component of the GI tract, with many
of them expressed along the entire GI tract. This work presents the ﬁrst overall road map of localization
of transporter genes in the GI tract.
 2011 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Membrane bound proteins represent about 27% of the entire
human proteome and most of them belong to three major func-
tional groups: receptors, transporters or enzymes [1]. The largest
superfamily of membrane bound proteins are G protein coupled
receptors (GPCRs) [2] while the second largest family is solute car-
riers (SLCs) comprising 384 known members [3]. SLCs outnumber
by far all other transporter classes, including ion channels, water
channels, pumps and ABC transporters. Amino acids, sugars, fatty
acids, inorganic ions, essential metals and drugs are transported
over the cell membrane by SLCs which act as exchangers, coupled
transporters and passive transporters [3,4]. We have recently clas-
siﬁed the entire repertoire of human SLC genes, classifying ﬁfteen
of the SLC subfamilies into four main groups, namely a-, b-, c-,
and d-groups [3]. About 40% of all SLCs are still orphans withoutl-time quantitative PCR.
J. Cedernaes).
Y-NC-ND license.known substrates. Many of these were just recently described
and thus in most cases lack biological characterization (details
about SLCs can be found in the SLC tables [5]).
Mapping gene localization for the entire gastrointestinal tract is
important since the different segments have such varied physio-
logical functions while still being a part of the same organ system.
Different molecules are absorbed or secreted in different parts of
the GI tract’s anatomical regions, such as in the proximal or distal
parts of the duodenum or ileum. Common diseases such as inﬂam-
matory bowel diseases and cancers of the GI tract are also known
to more often affect certain regions of the GI tract, and in some
cases more frequently its proximal or distal areas. For example,
Crohn’s disease more often affects the terminal ileum [6].
The importance of SLCs in absorption of nutrients and pharma-
ceuticals in the gastrointestinal (GI) tract is well established. For
example, mutations in SLC genes have been linked to Hartnup’s
disorder [7,8], congenital chloride diarrhea [9], glucose galactose
malabsorption [10] and lysinuric protein intolerance [11]. More-
over, expression levels of SLCs change in inﬂammatory bowel dis-
ease (IBD) [12] and colonic cancer [13,14]. The proximodistal
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ough manner. There is however previous evidence indicating that
SLC transporters are differentially expressed along the gut axis,
even when comparing proximal and distal subsegments [15–17].
Previous studies of SLCs in the GI tract have often employed immu-
noblotting, in situ hybridization and immunohistochemistry
[18,19]. Using RT-qPCR, SLC1a1 has been detected in the small
intestine using a three- and six-segment model while SLC1a4 has
been analyzed with the latter approach [20–22]. It should however
be noted that SLC 1 genes have not been mapped in other parts of
the GI tract. Members 5–11 of the SLC 7 family have also been
identiﬁed with Real-time (RT)-qPCR in the murine stomach, duo-
denum, jejunum, ileum and colon, but proximal vs. distal division
was disregarded [23]. Despite the large potential in RT-qPCR, pro-
viding excellent sensitivity, this method has to a limited degree
been applied to study localization of genes in subsections of the
GI tract. Better knowledge of SLCs’ proximodistal distribution in
the GI tract provides fundamental physiological information and
has clinical relevance relating to absorption of substrates as well
as for target drug design/delivery methods [24–26]. RT-qPCR al-
lows for a unique opportunity for simultaneous analysis of a high
number of mRNA proﬁles throughout complex systems, increasing
the probability of linking localization and physiological roles.
In the current paper, we present a longitudinal GI tract expres-
sion proﬁle of 78 SLCs, virtually covering all the SLC genes ex-
pressed in this region of the body. We also present a detailed
description as to whether the genes have been previously studied
in the GI tract and, where established, their subcellular localiza-
tion. We studied all SLCs that had evidence in either the Unigene
database or from an in-house tissue panel screening that they were
expressed in the intestine. The list of studied SLCs was further ex-
panded by a literature search. Expression of the SLCs was exam-
ined along the GI tract divided into 12 segments: the esophagus,
the corpus and the antrum of the stomach, the proximal and distal
parts of the duodenum, jejunum, ileum, and colon, and the cecum,
using RT-qPCR with a validated range of house keeping genes.2. Materials and methods
2.1. Animal handling and tissue isolation for quantitative real-time
qPCR
Male Dark Agouti rats (Scanbur AB, Sweden) weighing 200–
215 g, were maintained under constant conditions (12:12-h
light–dark cycle; 21 C). Before the experiments, the animals were
fasted overnight with free access to water. The following morning
at approximately 8 am, the animals were intraperitoneally anes-
thetized with Na-5-ethyl-1-(10-methyl-propyl)-2-thiobarbituric
acid (Inactin) at a dose of 125 mg per kg of body weight. Body
temperature was maintained at 37.5 ± 0.5 C using a temperature
regulator. Subsequently, a tracheotomy was performed and a can-
nula (PE-200) was inserted, ensuring free airways. The abdominal
cavity was opened by a midline incision and the following struc-
tures, about 5–10 mm in length, were isolated and removed: Distal
oesophagus (a few mm from the stomach), corpus and antrum of
the stomach, proximal duodenum (1 mm from the pylorus), distal
duodenum (4 cm from pylorus), proximal jejunum (9 cm from
pylorus), distal jejunum (19 cm from pylorus), proximal ileum
(29 cm from pylorus), distal ileum (2.5 cm from the ileocecal
valve), cecum, proximal colon (5 cm from ileocecal valve) and dis-
tal colon (12 cm from the ileocecal valve). The entire GI tract wall
was isolated for RT-qPCR analysis.
Following the operation, the animals were euthanized by an
intravenous bolus injection of a saturated KCl solution. All proto-
cols involving animals were approved by the Uppsala Ethic Com-mittee and comply with all policies and regulations outlined by
the Swedish Animal Protection Act.
2.2. RNA isolation and cDNA synthesis
RNA isolation and cDNA synthesis were performed as previ-
ously described [27].
2.3. RT-qPCR
In total the expression patterns of 78 SLC genes were analyzed
in the abovementioned twelve different tissue segments from the
rat GI tract. All primers were designed using Beacon Primer Design
7.0 software (Premier Biosoft, USA) and are documented in Supple-
mentary ﬁle 1. The RT-qPCR experiments were done as previously
described [27].
2.4. Data analysis and calculation of expression
The RT-qPCR data was analyzed with the Bio-Rad iQ5 software
v2.0 software (Bio-Rad Laboratories, Sweden). The analysis was
performed as previously described [27].
2.5. Data mining
Unigene is a resource that collects all available nucleotide se-
quences for genes and information about where they were col-
lected. An initial screening procedure for potential intestinal SLC
genes in the rat was performed by examining the expression anno-
tation in this database. We downloaded the Unigene data for rat
from NCBI’s FTP-page and queried it for SLC genes, which should
have a gene symbol starting with ‘‘Slc’’, expressed in intestinal tis-
sues using local scripts. The representative mRNA sequences of the
retrieved hits were downloaded from NCBI’s genebank and used
for primer design.
3. Results
Our initial selection of 83 SLC genes (for full list see Supplemen-
tary ﬁle 1) for the analysis in the rat GI tract was based on three
criteria. First, we used the Unigene database as described below.
Second, we utilized the in-house tissue panel of SLC genes analyzed
at our laboratory (Robert Fredriksson, unpublished data). Third, we
searched the relevant literature and identiﬁed other SLC genes
known to be expressed in the GI tract. We included genes that
had not been characterized in detail as well genes that were well
characterized as they could serve as reference genes.
The screening of Unigene for rat entries containing the SLC gene
symbol produced 342 positive results. We then selected entries
annotated as expressed in intestinal tissues, which gave us a set
of 52 Unigene entries representing potential intestinal SLC genes.
Forty seven of these genes are denoted to be expressed in the small
intestine and 24 in the large intestine. According to the database,
many of these SLCs were also expressed in other organs and tissue
types, including the brain (39 SLCs), prostate (38), kidney (37) and
liver (32).
Aside from the 52 genes derived from the Unigene database, we
expanded the studied transcripts by 31 additional SLCs based on
the aforementioned in-house tissue panel results and a literature
search.
All the studied segments, except for the esophagus and cecum,
were further divided into equal-length proximal and distal parts to
obtain a proximodistal expression pattern for each segment and
gene. The SLC genes from the Unigene dataset for which we were
able to construct working primers for (50 out of the 52), were all
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dataset as being accurate to show genes that are expressed in the
GI tract. Conversely, SLC7a3, SLC7a4 and SLC17a3 were not detect-
able [28,29], proving that our model did not produce false positive
outcomes.
Among the remaining 78 genes whose expression was detected,
44 (56%) were ubiquitously expressed, i.e. in all of the twelve stud-
ied GI tract segments (Fig. 1). Among the remaining SLC transcripts
present in the GI tract, only three (SLC14a2, SLC16a7, SLC26a9)
were identiﬁed in fewer than ﬁve segments. Three genes were
present in ﬁve segments (SLC1a7, SLC2a7, SLC14a1), three genes
in six (SLC1a2, SLC2a2, SLC5a9), two genes in seven and ﬁve genes
in eight segments. Among the non-ubiquitous SLCs, more genes
were expressed in the proximal and distal parts of the small intes-
tine and colon (Supplementary ﬁle 2). When proximal and distalFig. 1. Anatomical localization of SLCs along the GI tract, showing in which GI tract subseg
indicate no expression. The GI tract was divided into twelve subsegments: esophagus
jejunum, ileum and colon, and cecum.subsegments were compared, an equal number of non-ubiquitous
genes were found in both parts of the stomach (56). In the duode-
num, the proximal subsegment expressed 60 and the distal subseg-
ment 61 SLCs. This contrasts to the jejunum (75 vs 73), ileum (74
vs 69) and colon (73 vs 68), where slightly more genes were local-
ized to the proximal than the distal subsegments. The esophagus
and cecum expressed 51 and 59 SLCs, respectively. SLC families
that were consistently found throughout the GI tract were SLC27,
SLC35, SLC37, SLC38 and SLC43.
Orphan genes accounted for 14% (11) of the investigated genes.
The orphan genes were: SLC16a6, SLC22a17, SLC22a23, SLC25a36,
SLC25a38, SLC25a39, SLC25a44, SLC25a46, SLC35f5, SLC38a10, and
SLC43a3. All were found to be expressed throughout the GI tract.
In addition to our localization analysis, we reviewed the current
literature (Supplementary ﬁle 3) for the initial selection of SLCs. Allments the genes were expressed. Grey-colored cells indicate expression; white cells
, corpus and antrum of the stomach, proximal and distal parts of the duodenum,
Fig. 1 (continued)
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genes, were found to be known to be speciﬁcally expressed in
the intestine.
4. Discussion
SLCs play a crucial role in the GI tract cell function as well as
ability to obtain nutritive and non-nutritive substances. The cur-
rent study provides a unique, comprehensive overview of the local-
ization of genes encoding SLCs along the GI tract. We used a
detailed division of the GI tract, which took into account subtle,
otherwise undetectable differences in the localization of each gene
between proximal and distal GI subsegments. Using this model,
mRNA levels of 78 SLCs belonging to 28 SLC gene families were
analyzed (Fig. 1).
Many of the genes studied herein were found to be differently
expressed, i.e. present or absent, in the proximal versus distal parts
of each of the ‘‘classical’’ GI tract regions, which indicates that theGI segments should not be treated as genetically homogenous enti-
ties, but rather should be studied according to the precise localiza-
tion of their molecular components. This can facilitate better
understanding of the absorption processes, help in conceptualizing
the function of pharmacological agents, as well as decipher patho-
logical changes along the GI tract.
Longitudinal GI tract distribution proﬁles of the few SLC genes
reported thus far tend to be in good agreement with our results.
For example, SLC11a2, encoding the divalent metal ion transporter
1, DMT1, is expressed in the stomach and throughout the small and
large intestine [30,31]. High levels of the SLC15a1 gene encoding
di/tripeptide transporter PEPT1, have been shown throughout the
small intestine, while the cecum and stomach were devoid of
SLC15a1 mRNA [32,33].
The majority of the SLCs included in the analysis (44 out of 78,
or 56%) were found to be ubiquitously expressed along the GI tract.
Many of these genes were detected in parts of the GI tract where
absorption occurs as well as in segments unrelated to absorption.
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cules allowing their substrates to enter the general circulation
from the gut lumen and they may also be essential for functioning
of cells within the GI tract. Some of the SLCs studied in this project
transport the same type of substances and yet their localization in
the GI tract overlaps, which indicates that these transporters may
act concurrently and, if necessary, provide compensation for one
another. An excellent example of this overlap is the triplet of
genes: SLC7a2, SLC7a5 and SLC7a7.
More SLCs are expressed in gut regions with absorptive func-
tions, such as the duodenum, jejunum, ileum and colon (see Sup-
plementary ﬁle 2). This difference is somewhat more apparent
when the data are analyzed according to the classical anatomical
dissection without the proximodistal segment subdivision; in that
case, the jejunum is the region with the highest number of differ-
entially expressed SLCs. As the entire GI tract wall was used in our
analysis, the ubiquitous presence of many SLC transporters may re-
ﬂect gene expression in non-mucosal layers of the GI tract wall. For
example, SLC5a1 encoding a protein dubbed SGLT1, has been found
not in the mucosa, but in the myenteric plexus of the stomach and
colon [34]. This may explain why in our study SLC5a1 expression
was found not only in the small intestine but also in the stomach,
colon and esophagus.
When analyzing the distribution according to our twelve-seg-
ment model, the highest number of SLCs was detected in the prox-
imal segment of the jejunum (see Supplementary ﬁle 2). It is
noteworthy that this distribution pattern differs to some extent
from the bell-shaped SLC expression curve seen if the expression
was divided according to the classical GI tract division, i.e. with
no proximal and distal divisions. Furthermore, in the ileum, 74
SLCs were expressed in the proximal subsegment, whereas 69
transcripts were identiﬁed in the distal subsegment. This shows
that gene localization patterns vary along the length of a given
intestinal region, which signiﬁes the need of applying a detailed
proximodistal dissection model in future studies.
Some of our expression proﬁles differ somewhat from previous
ﬁndings. This can be due to methodological differences, including
dissection as other authors performed biopsies of only mucosa or
used entire GI tract segments. Differences may also be species-
or individual-speciﬁc; the latter especially in GI tract pathology.
Whereas Slitt et al. report that SLC22a1 is expressed in the stomach
[35], we found no expression in the corpus, but in the antrum. The
mRNA expression does not always correlate with protein expres-
sion, since the protein turnover rate can vary, and translational
or post-translational regulation of the genes can occur [36,37]. Fu-
ture studies should therefore also study protein expression of the
genes analyzed in this study.
It is known that mRNA levels of genes regulating substrate
absorption may vary due to the time of the day and to the feeding
state [38–40]. In the current study, gene expression levels were
measured in the morning after an overnight fast and it is important
to be aware that the expression could be different in the fed state
or at a different time of the day. The effect of fasting on SLC gene
expression in the murine small intestine has been studied and
about 15% of the studied 243 SLCs were differentially expressed
[41].
Finally, a large proportion of genes in this study (11 out of 78),
were orphans, belonging to six SLC gene families. All were ubiqui-
tously expressed, which suggests a potentially important role for
the functioning of the entire GI tract. Most orphans belonged to
the SLC25 family, known as the mitochondrial transporters [42].
Their widespread distribution could possibly suggest overlapping
physiological functions. Almost all of the SLC genes found in the
Unigene database were found to be expressed in our model and
this was also supported by the literature, validating this database
as a reliable initial screening tool.In sum, we present the most comprehensive and detailed char-
acterization of 78 SLC gene expression in the rat GI tract. The re-
sults show that the majority are ubiquitously expressed in the GI
tract. Among the remaining genes, most are detected in more than
ﬁve segments. We characterized the expression of eleven orphans.
Widespread distribution of SLCs in the GI tract points out to an
important role for SLCs in gut physiology. Our twelve-segment
model provides a unique illustration of the intestinal SLC mRNA
distribution pattern. Proximodistal differences in gene localization
found in our study suggest that employing a detailed anatomical
division is desirable when analyzing gene expression in the GI
tract.
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